X
XBI
State Street SPDR S&P Biotech ETF
$146.77
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of State Street SPDR S&P Biotech ETF in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Posts
No posts about XBI yet.
About State Street SPDR S&P Biotech ETF
XBI is the SPDR S&P Biotech ETF, a fund that pools money to buy an equal-weighted basket of U.S. biotechnology and pharmaceutical stocks, including many small and mid-sized clinical-stage drug developers alongside larger names. Rather than betting on one company, it makes money for holders by tracking the ups and downs of the biotech industry as a whole. It doesn't develop drugs or generate its own revenue since it's a fund, not an operating business.